Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5

American Journal of Roentgenology

Volumn 191, Issue 2, 2008, Pages 475-479

  Chen, Chao Jung ^a   Lee, Bi Fang ^a   Yao, Wei Jen ^a   Cheng, Lili ^a   Wu, Pei Shan ^a   Ching, Lin Chu ^a   Chiu, Nan Tsing ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Delayed imaging; FDG; Inflammation; Lung nodules; Malignancy

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BENIGN TUMOR; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOCOCCOSIS; DIAGNOSTIC ACCURACY; DRUG RETENTION; DRUG UPTAKE; FEMALE; GRANULOMATOUS INFLAMMATION; HIGH RISK PATIENT; HUMAN; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG FIBROSIS; LUNG NODULE; LUNG SQUAMOUS CELL CARCINOMA; LUNG TUBERCULOSIS; LUNG TUMOR; MALE; MALIGNANT NEOPLASTIC DISEASE; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; STANDARD UPTAKE VALUE; VALIDITY; ALGORITHM; COMPUTER ASSISTED DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; LUNG DISEASE; MIDDLE AGED; NONPARAMETRIC TEST; SCINTISCANNING;

ADULT; AGED; ALGORITHMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; ROC CURVE; SOLITARY PULMONARY NODULE; STATISTICS, NONPARAMETRIC; TUBERCULOSIS, PULMONARY;

EID: 49149092346     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.3457     Document Type: Article

References (27)

1. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001; 285:914-924
2. Duhaylongsod FG, Lowe VJ, Patz EF Jr, Vaughn AL, Coleman RE, Wolfe WG. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). J Thorac Cardiovasc Surg 1995; 110:130-139
3. Lowe VJ, Duhaylongsod FG, Patz EF, et al. Pulmonary abnormalities and PET data analysis: a retrospective study. Radiology 1997; 202:435-439
4. Higashi K, Ueda Y, Seki H, et al. Fluorine-18-FDG PET imaging is negative in bronchioalveolar carcinoma. J Nucl Med 1998; 39:1267-1269
5. Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer 2004; 45:19-27
6. Knight SB, Delbeke D, Stewart JR, Sandler MP. Evaluation of pulmonary lesions with FDG-PET. Chest 1996; 109:982-988
7. Ichiya Y, Kuwabara Y, Sasaki M, et al. FDG-PET in infectious lesions: the detection and assessment of lesion activity. Ann Nucl Med 1996; 10:185-191
8. Matthies A, Hickeson M, Cuchiara A, Alavi A. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 2002; 43:871-875
9. Kubota K, Itoh M, Ozaki K, et al. Advantage of delayed whole-body FDG-PET imaging for tumor detection. Eur J Nucl Med 2001; 28:696-703
10. 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001; 42:1412-1417
11. Xiu Y, Bhutani C, Dhurairaj T, et al. Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity. Clin Nucl Med 2007; 32:101-105
12. 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes? Eur J Nucl Med Mol Imaging 2005; 32:541-548
13. Dobert N, Hamscho N, Menzel C, Neuss L, Kovacs AF, Grunwald F. Limitations of dual time point FDG PET imaging in the evaluation of focal abdominal lesions. Nuklearmedizin 2004; 43:143-149
14. Lowe VJ, Delong DM, Hoffman JM, Coleman RE. Optimum scanning protocol for FDG PET evaluation of pulmonary malignancy. J Nucl Med 1995; 36:883-887
15. 18F-FDG PET versus nodule-enhancement CT. AJR 2006; 187:1361-1367
16. Zhuang H, Hustinx R, Alavi A. Effect of diazepam on the efficacy of dual-phase FDG PET imaging. Eur J Nucl Med Mol Imaging 2006; 33:228-229
17. Winer-Muram HT. The solitary pulmonary nodule. Radiology 2006; 239:34-49
18. Jeong YJ, Yi CA, Lee KS. Solitary pulmonary nodules: detection, characterization, and guidance for further diagnostic workup and treatment. AJR 2007; 188:57-68
19. 18FFDG-PET imaging in the detection of hepatocellular carcinoma. Nucl Med Commun 2005; 26:315-321
20. Hustinx R, Smith RJ, Benard F, et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur J Nucl Med 1999; 26:1345-1348
21. 18FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med 2002; 43:173-180
22. 18FDG uptake in soft tissue masses. Eur J Nucl Med 1999; 26:22-30
23. 18F]fluoro-2-deoxyglucose positron emission tomography in chronic bacterial osteomyelitis. Nucl Med Commun 2004; 25:819-823
24. Mochizuki T, Tsukamoto E, Kuge Y, et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med 2001; 42:1551-1555
25. 18F]FDG uptake in nude mice with tumors and inflammation: correlated with histopathology and micro-autoradiography. Kaohsiung J Med Sci 2005; 21:258-266
26. 18F] FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung. Neoplasia 2005; 7:369-379
27. Gupta A, Raghubir R. Energy metabolism in the granulation tissue of diabetic rats during cutaneous wound healing. Mol Cell Biochem 2005; 270:71-77